GTC

Ghost Tree Capital Portfolio holdings

AUM $276M
1-Year Est. Return 49.13%
This Quarter Est. Return
1 Year Est. Return
+49.13%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$287M
AUM Growth
-$23.7M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
78
New
Increased
Reduced
Closed

Top Buys

1
+$11.8M
2
+$7.12M
3
+$6.11M
4
CGON icon
CG Oncology
CGON
+$5.84M
5
CRBP icon
Corbus Pharmaceuticals
CRBP
+$5.34M

Top Sells

1
+$11.1M
2
+$9.11M
3
+$6.65M
4
TGTX icon
TG Therapeutics
TGTX
+$5.78M
5
INSM icon
Insmed
INSM
+$5.7M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SGMT icon
51
Sagimet Biosciences
SGMT
$245M
$770K 0.24%
225,000
ITCI
52
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$685K 0.21%
+10,000
MGNX icon
53
MacroGenics
MGNX
$86.6M
$638K 0.2%
+150,000
PMVP icon
54
PMV Pharmaceuticals
PMVP
$69.4M
$608K 0.19%
375,000
-300,000
PTCT icon
55
PTC Therapeutics
PTCT
$5.76B
$581K 0.18%
+19,000
RVNC
56
DELISTED
Revance Therapeutics, Inc.
RVNC
$578K 0.18%
225,000
-225,000
NTLA icon
57
Intellia Therapeutics
NTLA
$1.02B
$560K 0.18%
25,000
ANTX icon
58
AN2 Therapeutics
ANTX
$31.2M
$472K 0.15%
219,331
CTMX icon
59
CytomX Therapeutics
CTMX
$597M
$366K 0.11%
300,000
-300,000
ALT icon
60
Altimmune
ALT
$363M
– –
-250,000
AQST icon
61
Aquestive Therapeutics
AQST
$737M
– –
-702,941
ATXS icon
62
Astria Therapeutics
ATXS
$706M
– –
-115,000
JBIO
63
Jade Biosciences
JBIO
$423M
– –
-6,429
COGT icon
64
Cogent Biosciences
COGT
$2.07B
– –
-450,000
EYPT icon
65
EyePoint Pharmaceuticals
EYPT
$926M
– –
-90,000
GERN icon
66
Geron
GERN
$683M
– –
-800,000
GPCR icon
67
Structure Therapeutics
GPCR
$1.89B
– –
-75,000
KALV icon
68
KalVista Pharmaceuticals
KALV
$545M
– –
-200,000
LRMR icon
69
Larimar Therapeutics
LRMR
$296M
– –
-210,603
MDGL icon
70
Madrigal Pharmaceuticals
MDGL
$11.1B
– –
-6,500
NTRA icon
71
Natera
NTRA
$27.4B
– –
-25,000
PTGX icon
72
Protagonist Therapeutics
PTGX
$4.95B
– –
-75,000
QURE icon
73
uniQure
QURE
$1.71B
– –
-165,000
RARE icon
74
Ultragenyx Pharmaceutical
RARE
$2.96B
– –
-20,000
RAPT icon
75
RAPT Therapeutics
RAPT
$718M
– –
0
1 2
3
4